LISATA THERAPEUTICS, INC. — Director's Dealing 2012

Jul 23, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-07-20

Reporting Person: Wei Eric (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-20	Common Stock, par value $0.001 per share	G	15306	—	Acquired	22545180	Indirect

Footnotes

F1: On July 20, 2012, Mr. Wei transferred 15,306 shares of common stock, par value $0.001 per share (the "Common Stock"), of NeoStem, Inc. (the "Company"), owned directly by Mr. Wei to RimAsia Capital Partners Manager, Ltd., a Cayman Islands exempted company ("RimAsia Manager") for no consideration.

F2: These securities are held as to 22,409,874 shares of Common Stock by RimAsia Capital Partners L.P., a Cayman Islands exempted limited partnership ("RimAsia LP"), and as to 135,306 shares of Common Stock by RimAsia Manager, respectively. The 135,306 shares of Common Stock held by RimAsia Manager consist of (i) the 15,306 shares of Common Stock transferred by Mr. Wei to RimAsia Manager on July 20, 2012, as described in footnote 1, and (ii) 120,000 shares of Common Stock transferred by Mr. Wei to RimAsia Manager on January 12, 2012, which the reporting person's Form 4 dated January 13, 2012 had erroneously reported as having been transferred to RimAsia LP.

F3: RimAsia Capital Partners GP, L.P., a Cayman Islands exempted limited partnership ("RimAsia GP"), is the general partner of RimAsia LP. RimAsia Manager is the Fund Manager of RimAsia GP and the Manager of RimAsia LP. Mr. Wei is the managing partner of RimAsia LP, an indirect partner of RimAsia GP, a director of RimAsia Capital Partners GP, Ltd. and a director of RimAsia Manager. As a result, Mr. Wei may be deemed to have sole power to vote certain of the securities held by RimAsia LP and RimAsia Manager. Mr. Wei disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and the inclusion of these securities shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Securities Exchange Act or for any other purpose.